LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 46 filers reported holding LANDOS BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,584,000 | -17.0% | 3,975,722 | -7.0% | 0.06% | -25.0% |
| Q2 2022 | $3,112,000 | -50.7% | 4,275,722 | 0.0% | 0.08% | -38.9% |
| Q1 2022 | $6,307,000 | -69.3% | 4,275,722 | 0.0% | 0.13% | -56.3% |
| Q4 2021 | $20,523,000 | -67.1% | 4,275,722 | 0.0% | 0.30% | -68.1% |
| Q3 2021 | $62,426,000 | +28.8% | 4,275,722 | 0.0% | 0.94% | +28.7% |
| Q2 2021 | $48,457,000 | +26.4% | 4,275,722 | 0.0% | 0.73% | +22.2% |
| Q1 2021 | $38,328,000 | – | 4,275,722 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $2,696,000 | 2.05% |
| Perceptive Advisors | 14,869,915 | $21,933,000 | 0.44% |
| RTW INVESTMENTS, LP | 4,275,722 | $6,307,000 | 0.13% |
| ArchPoint Investors | 128,750 | $190,000 | 0.07% |
| Orbimed Advisors | 283,217 | $418,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,000 | $235,000 | 0.01% |
| Walleye Capital LLC | 93,533 | $138,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 158,875 | $234,000 | 0.00% |
| Renaissance Technologies | 340,500 | $502,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,324 | $3,000 | 0.00% |